Adults with attention deficit hyperactivity disorder have a significantly greater risk of developing dementia than those without the disorder, new research suggests.
Solriamfetol may be a safe and effective nonstimulant treatment for adults with ADHD, results of a small, double-blind, placebo-controlled pilot study suggest
The prevalence of attention-deficit/hyperactivity disorder (ADHD) among US children and adolescents remained stable at around 10% from 2017 through 2022, new data show.